These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 31369200)

  • 21. Non-invasive biomarkers of Fontan-associated liver disease.
    Emamaullee J; Khan S; Weaver C; Goldbeck C; Yanni G; Kohli R; Genyk Y; Zhou S; Shillingford N; Sullivan PM; Takao C; Detterich J; Kantor PF; Cleveland JD; Herrington C; Ram Kumar S; Starnes V; Badran S; Patel ND
    JHEP Rep; 2021 Dec; 3(6):100362. PubMed ID: 34693238
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk Factors for Mid-Term Liver Disease After the Fontan Procedure.
    Oka N; Miyamoto T; Tomoyasu T; Hayashi H; Miyaji K
    Int Heart J; 2020 Sep; 61(5):979-983. PubMed ID: 32921662
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Morphologic Alterations Precede Functional Hepatic Impairment as Determined by
    Schleiger A; Kramer P; Sallmon H; Jentsch N; Pileckaite M; Danne F; Schafstedde M; Müller HP; Müller T; Tacke F; Jara M; Stockmann M; Berger F; Ovroutski S
    Front Cardiovasc Med; 2021; 8():764009. PubMed ID: 35004881
    [No Abstract]   [Full Text] [Related]  

  • 24. Severe Fontan-Associated Liver Disease and Its Association With Mortality.
    Guerrero-Chalela CE; Therrien J; Grossman Y; Guo L; Liu A; Marelli A
    J Am Heart Assoc; 2023 Oct; 12(19):e024034. PubMed ID: 37776221
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Portal and centrilobular hepatic fibrosis in Fontan circulation and clinical outcomes.
    Wu FM; Jonas MM; Opotowsky AR; Harmon A; Raza R; Ukomadu C; Landzberg MJ; Singh MN; Valente AM; Egidy Assenza G; Perez-Atayde AR
    J Heart Lung Transplant; 2015 Jul; 34(7):883-91. PubMed ID: 25863891
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Research priorities in Fontan-associated liver disease.
    Khan S; Aziz H; Emamaullee J
    Curr Opin Organ Transplant; 2020 Oct; 25(5):489-495. PubMed ID: 32833705
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pretransplantation and Post-Transplantation Liver Disease Assessment in Adolescents Undergoing Isolated Heart Transplantation for Fontan Failure.
    Rodriguez DS; Mao C; Mahle WT; Kanter KR; Alazraki A; Braithwaite K; Rytting H; Caltharp S; Magliocca JF; Romero R
    J Pediatr; 2021 Feb; 229():78-85.e2. PubMed ID: 32976893
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence and characterization of fibrosis in surveillance liver biopsies of patients with Fontan circulation.
    Surrey LF; Russo P; Rychik J; Goldberg DJ; Dodds K; O'Byrne ML; Glatz AC; Rand EB; Lin HC
    Hum Pathol; 2016 Nov; 57():106-115. PubMed ID: 27476041
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Liver function and portal-systemic shunting quantified by the oral cholate challenge test and risk for large oesophageal varices.
    Hassanein T; Keaveny AP; Mantry P; Smith AD; McRae MP; Kittelson J; Helmke S; Everson GT;
    Aliment Pharmacol Ther; 2024 Jul; 60(2):246-256. PubMed ID: 38778481
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prediction of Fontan-Associated Liver Disease Using a Novel Cine Magnetic Resonance Imaging "Vortex Flow Map" in the Right Atrium.
    Ishizaki U; Nagao M; Shiina Y; Fukushima K; Takahashi T; Shimomiya Y; Matsuo Y; Inai K; Sakai S
    Circ J; 2018 Jul; 82(8):2143-2151. PubMed ID: 29780065
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic Value of Liver and Spleen Stiffness in Patients with Fontan Associated Liver Disease (FALD): A Case Series with Histopathologic Comparison.
    Padalino MA; Chemello L; Cavalletto L; Angelini A; Fedrigo M
    J Cardiovasc Dev Dis; 2021 Mar; 8(3):. PubMed ID: 33809668
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatic changes in the failing Fontan circulation.
    Kiesewetter CH; Sheron N; Vettukattill JJ; Hacking N; Stedman B; Millward-Sadler H; Haw M; Cope R; Salmon AP; Sivaprakasam MC; Kendall T; Keeton BR; Iredale JP; Veldtman GR
    Heart; 2007 May; 93(5):579-84. PubMed ID: 17005713
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictive value of biomarkers of hepatic fibrosis in adult Fontan patients.
    Wu FM; Earing MG; Aboulhosn JA; Johncilla ME; Singh MN; Odze RD; Ukomadu C; Gauvreau K; Landzberg MJ; Valente AM;
    J Heart Lung Transplant; 2017 Feb; 36(2):211-219. PubMed ID: 27592026
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Within-individual reproducibility of a dual sample oral cholate challenge test (DuO) and simplified versions of the HepQuant SHUNT test.
    McRae MP; Kittelson J; Helmke SM; Everson GT
    Clin Transl Sci; 2024 Apr; 17(4):e13786. PubMed ID: 38558534
    [TBL] [Abstract][Full Text] [Related]  

  • 35. EASL-ERN position paper on liver involvement in patients with Fontan-type circulation.
    Téllez L; Payancé A; Tjwa E; Del Cerro MJ; Idorn L; Ovroutski S; De Bruyne R; Verkade HJ; De Rita F; de Lange C; Angelini A; Paradis V; Rautou PE; García-Pagán JC
    J Hepatol; 2023 Nov; 79(5):1270-1301. PubMed ID: 37863545
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transfemoral-Transcaval Liver Biopsy (TFTC) and Transjugular Liver Biopsy (TJLB) in Patients with Fontan-Associated Liver Disease (FALD).
    Shahid MU; Frenkel Y; Kuc N; Golowa Y; Cynamon J
    Cardiovasc Intervent Radiol; 2024 Jul; 47(7):875-882. PubMed ID: 38816503
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fontan-associated liver disease and hepatocellular carcinoma in adults.
    Kogiso T; Tokushige K
    Sci Rep; 2020 Dec; 10(1):21742. PubMed ID: 33303924
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fontan-associated liver disease: A review.
    Gordon-Walker TT; Bove K; Veldtman G
    J Cardiol; 2019 Sep; 74(3):223-232. PubMed ID: 30928109
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fontan-Associated Liver Disease: A Review.
    Téllez L; Rodríguez-Santiago E; Albillos A
    Ann Hepatol; 2018 Mar; 17(2):192-204. PubMed ID: 29469053
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heterogeneous outcomes of liver disease after heart transplantation for a failed Fontan procedure.
    Ybarra AM; Khanna G; Turmelle YP; Stoll J; Castleberry CD; Scheel J; Ballweg JA; Ameduri R; Kimberling M; Makil E; Birnbaum BF; Exil V; Canter CE; Simpson KE
    Pediatr Transplant; 2021 Dec; 25(8):e14094. PubMed ID: 34296503
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.